Skip to main content
. 2013 Jun 21;8(6):e66328. doi: 10.1371/journal.pone.0066328

Figure 1. Serum Fuc-Hpt levels were significantly elevated in biopsy-proven NASH patients.

Figure 1

(A) Serum Fuc-Hpt levels in each group (normal controls, non-NASH patients, NASH patients). Horizontal grey lines indicate the mean values of Fuc-Hpt in each group. NC, normal controls. (B) ROC curves for Fuc-Hpt and the M30 antigen for the discrimination of NASH.